TP53 and breast carcinoma: Patients with breast cancer carrying the TP53 mutation were diagnosed with a higher glucose-6-phosphate isomerase (GPI) gene expression that indicates higher level of glycolysis in tumor cells and correlates with the degree of tumor malignancy (57).